Hyperthermic Intraperitoneal Chemotherapy for Abdominal Cancers

Hyperthermic Intraperitoneal Chemotherapy for Abdominal Cancers

MUSC surgeon Ramsay Camp, M.D., discusses HIPEC for patients with cancer within the peritoneum, which is hard to treat with intravenous chemotherapy. With highly concentrated heated chemotherapy and delivery directly to the cancer through abdominal surgery, patients experience less exposure and better results.


Published

July 26, 2019

Created by

The Medical University of South Carolina

Related Presenters

Ramsay Camp, M.D.

Ramsay Camp, M.D.

Associate Professor of Surgery - Surgical Oncology

View full profile